Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model


ERTILAV M., HUR E., Bozkurt D. , SIPAHI S., TİMUR O., SARSIK B. , ...More

NEPHROLOGY, vol.16, no.6, pp.552-557, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 6
  • Publication Date: 2011
  • Doi Number: 10.1111/j.1440-1797.2011.01460.x
  • Title of Journal : NEPHROLOGY
  • Page Numbers: pp.552-557

Abstract

Aim: Encapsulated peritoneal sclerosis is characterized by neoangiogenesis and fibrosis. Octreotide, a somatostatin analogue is a well-known antifibrotic, antiproliferative and anti-angiogenic agent. The aim of the study is to evaluate the effects of octreotide in encapsulated peritoneal sclerosis-induced neoangiogenesis and fibrosis and compare the results with resting.